[Congressional Record Volume 170, Number 79 (Tuesday, May 7, 2024)]
[House]
[Page H2937]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

            By Mr. DAVIS of North Carolina:
        H.R. 8267.
        Congress has the power to enact this legislation pursuant 
     to the following:
        Article I, Section 8, Clause 18.
        The single subject of this legislation is:
        To amend titles XVIII and XIX of the Social Security Act 
     to provide that priority research drugs shall not be treated 
     as line extensions of existing drugs for purposes of 
     calculating manufacturer rebates under the Medicare and 
     Medicaid programs.